Willie L. Whitter

2.5k citations
19 papers · 2.0k indexed · 1 hit paper · h-index 13
Topics
Neuropeptides and Animal Physiology (10 papers)Chemical Synthesis and Analysis (6 papers)Peptidase Inhibition and Analysis (4 papers)
Partner nations
United States

In The Last Decade

Willie L. Whitter

19 papers receiving 1.9k citations

Hit Papers

Methods for drug discovery: development of potent, select...198820262000201319882505007501000

Peers

Willie L. Whitter
Comparison fields: 5 of 93
  • Molecular Biology 1.1k
  • Organic Chemistry 1.0k
  • Cellular and Molecular Neuroscience 528
  • Pharmacology 228
  • Computational Theory and Mathematics 197
Replace Kenneth E. Rittle with:
Kenneth E. Rittle United States
Robert M. DiPardo United States
B. Evans United States
Dhanapalan Nagarathnam United States
Paul J. Kling United States
G. F. Lundell United States
Sander G. Mills United States
Deborah J. Cerino United States
Timothy J. Hagen United States
Mark G. Bock United States
Willie L. Whitter relative to Kenneth E. Rittle United States Kenneth E. Rittle's profile →
Citations per field
00.5×1.5×
Kenneth E. Rittle · 1×
Citations per year

Countries citing papers authored by Willie L. Whitter

Since Specialization
Citations

This map shows the geographic impact of Willie L. Whitter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willie L. Whitter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willie L. Whitter more than expected).

Fields of papers citing papers by Willie L. Whitter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willie L. Whitter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willie L. Whitter. The network helps show where Willie L. Whitter may publish in the future.

Co-authorship network of co-authors of Willie L. Whitter

This figure shows the co-authorship network connecting the top 25 collaborators of Willie L. Whitter. A scholar is included among the top collaborators of Willie L. Whitter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willie L. Whitter. Willie L. Whitter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 3
2 16
3 51
4 28
5 1
6 18
7 16
8 250
9
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsbreakdown →
1177
10 30
11 56
12 20
13 3
14 52
15 6
16 253
17 10
18 7
19 18

About Willie L. Whitter

Willie L. Whitter is a scholar working on Cellular and Molecular Neuroscience, Pharmaceutical Science and Virology, having authored 19 papers that have together received 2.0k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (10 papers), Chemical Synthesis and Analysis (6 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Organic Chemistry (1.0k citations), Cellular and Molecular Neuroscience (528 citations) and Toxicology (85 citations). Willie L. Whitter has collaborated with scholars based in United States. Frequent co-authors include Roger Freidinger, Mark G. Bock, Kenneth E. Rittle, Robert M. DiPardo, B. Evans, Daniel F. Veber, Paul Anderson, G. F. Lundell, Victor J. Lotti and Raymond S.L. Chang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Controlled Release and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026